It’s well-known that in times of tragedy, scammers pop up and try to capitalize on dire situations. COVID was no different in that regard, with many fraudsters trying to earn off of others’ misfortunes. First there were the protective equipment shortages when people stocked up and sold them back for insane prices. After that, there were many miracle cures and things alike that could help you recover from the disease. However, after vaccines started rolling out and the situation stabilized, these scammers had to get a bit more creative.
Unfortunately, that doesn’t mean scammers just quit, as we can see from the case of Omri Shafran and his company. Texas Medical Tech, one of the larger PPE distributors in Houston, doesn’t seem to be complacent with its earnings. Instead, it has opted to make underhanded moves to attract investors to a potential Ponzi scheme. Now that medical funding is most needed, drawing that away for your own scams is especially malicious.
But we’re getting ahead of ourselves, and we’re accusing Shafran without presenting his case. We do feel like it’s clear-cut enough to make those accusations straight away, but we’ll let you be the judge of that. The rest of our text should serve as a warning for potential investors in Shafran’s projects. In broader strokes, it is also a cautionary message to thoroughly look into the projects you want to invest in.
The controversy comes from one of Texas Medical Technology’s last projects, called iNitrile. It’s a surgical glove donning device that would speed up putting on protective equipment. It would also theoretically reduce waste.
But what does that have to do with COVID, you might ask. Well, the demand for protective equipment has never been higher. COVID has emphasized the importance of PPE and tech solutions for it to the highest degree. It’s apparent that Shafran chose a project that is currently in high demand. If the pandemic weren’t happening, we doubt Shafran would be trying to peddle a glove donning device.
But a glove donning device simply sounds like a solid business idea, so what’s the problem? The answer is twofold, the first part of that being that the project is likely stolen. A nearly identical machine is nearing the end of its development cycle and soon going into mass production. The machine predates iNitrile, and an entirely different company developed it.
That might sound like an unfortunate coincidence until you learn that Shafran met with the other company in 2020. The company refused to cooperate with him on the grounds of too much vagueness surrounding Shafran. On top of that, the company is currently undergoing a legal process against Shafran and Texas Medical Technology. That’s why we can’t name the firm or provide any further details.
Another piece of evidence against Shafran is on his other company’s website. TexasTec health, until recently, displayed the image of the original machine while marketing it as iNitrile. The picture didn’t match any of iNitrile’s other promotional material, and we’ll let you see the difference. The first image is the original device and the second is iNitrile:
Patent infringement is bad enough, but we mentioned another significant problem we’ll zero in on now. If you’ve looked at the two images above, you might have noticed something odd. The original device looks fine, while iNitrile seems almost like a computer-generated image. Note that Shafran is claiming the machine is at the third-generation prototype stage. That would surely mean it’s at least a semi-functioning machine by now, right?
We’d like you to look at the following Youtube videos from iNitrile itself:
The first is obviously made out of spliced pictures. However, the second allegedly is a functioning prototype. Somehow, it still cuts away before everything the demonstrator does, showing no actual functionality. We don’t know who Shafran intends to fool with that display, but it’s egregiously fake.
There’s further proof that there’s no actual iNitrile at all and that it’s all a Ponzi scheme. For example, Texas Medical Technology claims that its production facility has around 300 employees. Our informant that’s been inside the building claims that 30-50 is a much more accurate estimate. Furthermore, the facility doesn’t seem to do any actual production, but rather PPE packaging and shipping. Also, they found no traces of any sort of assembly, let alone an actual iNitrile machine.
For a project that’s allegedly so far down its development course, that’s unacceptable. Shafran’s factory couldn’t have been able to develop the product in his alleged time frame. We’d go as far as to say it’s unlikely the facility could develop such a product at all.
Shafran, and his peers, Jad Shraim and Dimitri Menin, are likely trying to scam investors out of their money. We recommend staying away from their products and being careful of what you invest in.